[The immune system: new therapeutic targets].

Area of Science:

• Immunology
• Transplantation Science
• Autoimmune Disease Research

Context:

• Controlling immune responses is vital for patients with autoimmune diseases and alloreactivity post-transplantation.
• Current broad-spectrum immunosuppression leads to significant side effects like immunodeficiency and increased infectious risks.
• Need for more selective therapeutic strategies to mitigate these risks.

Purpose:

• To explore novel therapeutic approaches for precise immune system targeting.
• To develop strategies that minimize the side effects of immune control.
• To identify and validate new targets for autoimmune disease and transplantation management.

Summary:

• Advances in understanding immune mechanisms enable the development of targeted therapies.
• Potential targets include modulating cytokine profiles, neutralizing inflammatory cytokines, inducing regulatory lymphocytes, and blocking adhesion molecules.
• These approaches aim to normalize T and B cell tolerance and modulate immune cell interactions.

Impact:

• Successful validation of these selective strategies can significantly improve patient outcomes in autoimmune diseases and transplantation.
• Reduced immunosuppression will lower the incidence of opportunistic infections.
• Personalized immunotherapies hold promise for more effective and safer immune management.